As a result of years of research, we have developed a wide range of functional OrganoAssays on the OrganoPlatform to study complex, progressive, and multifactorial diseases. Traditional cell cultures and animal models often fall short in replicating the intricacies of these chronic conditions. 

Our assays bridge this gap by leveraging human organoids and organ-on-a-chip systems that mimic the native human tissue environment. This enables reliable toxicology screening, high content screening, and effective preclinical testing of drugs, producing data that truly reflect human physiological responses.